The State Key Laboratory of Medicinal Chemical Biology received official approval in 2011. Guided by the visionary concept of "Making life visible, controllable, and creatable," proposed by the academician Zihe Rao, our founding director and former president, we have harnessed the collective expertise of Nankai University in pharmacy, chemistry, biology, medicine, and other related disciplines. Furthermore, we actively pursue the integration of science and education, as well as industry and education.

Our laboratory has successfully undertaken 332 national-level projects, securing a total funding of approximately 647 million RMB. These projects include 34 Key Research and Development Programs, 1 innovative research group project funded by the NSFC, and 1 national major scientific instrument project funded by the NSFC. Additionally, we have embarked on 180 commercial research projects, acquiring a total funding of approximately 147 million RMB. Our innovation and research excellence are reflected in the 473 patents granted to our laboratory, including 17 PCT patents.

In our pursuit of understanding scientific issues related to pathogenic microorganism infections, cellular responses, and other relevant areas, we have developed various technical methodologies. These include the identification of novel drug targets based on chemical biology, drug delivery systems with targeted specificity, and the discovery of characteristic drugs. Notably, our efforts have yielded fruitful results in crucial areas such as viral infection mechanisms and prevention, cellular immunity and response, as well as the total synthesis and modification of natural drugs.